Perspective Therapeutics, Inc. — Director's Dealing 2016

Jan 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2016-01-13

Reporting Person: Hoffmann Alan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-13	Stock Options	$0.64	A	25000	Acquired	2026-01-12	Common Stock (25000)	Direct